Axsome Therapeutics Inc (AXSM.OQ)
AXSM.OQ on NASDAQ Stock Exchange Global Market
3.35USD
15 Oct 2018
3.35USD
15 Oct 2018
Change (% chg)
$0.19 (+6.01%)
$0.19 (+6.01%)
Prev Close
$3.16
$3.16
Open
$3.14
$3.14
Day's High
$3.38
$3.38
Day's Low
$3.14
$3.14
Volume
36,080
36,080
Avg. Vol
32,512
32,512
52-wk High
$5.90
$5.90
52-wk Low
$2.05
$2.05
Select another date:
Tue, May 8 2018
BRIEF-Axsome Therapeutics Reports Q1 Loss Per Share Of $0.19
* AXSOME THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
BRIEF-Axsome Therapeutics Announces First Patient Enrolled In Phase 2 Clinical Trial Of AXS-05 In Smoking Cessation
* AXSOME THERAPEUTICS ANNOUNCES FIRST PATIENT ENROLLED IN PHASE 2 CLINICAL TRIAL OF AXS-05 IN SMOKING CESSATION Source text for Eikon: Further company coverage:
BRIEF-Axsome Therapeutics Appoints Nick Pizzie, Cpa, Mba, As Chief Financial Officer
* AXSOME THERAPEUTICS APPOINTS NICK PIZZIE, CPA, MBA, AS CHIEF FINANCIAL OFFICER
Select another date: